Search research articles
Contact Us
Filters
Showing results (941-950 of 947) with videos related to
Page
of 95
Sort By:
You have reached the last page of results.
This site can display upto 947 results.
Cell Reports. Medicine
|
June 19, 2024
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104)
Chao Zhang, Yu-Xuan Sun, Ding-Cheng Yi, et al.
Cell Reports
|
August 8, 2024
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC
Yang-Si Li, Wen-Pu Lai, Kai Yin, et al.
Nature Medicine
|
July 24, 2023
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial
Si-Yang Maggie Liu, Hai-Yan Tu, Xue-Wu Wei, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2025
Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases
Yang-Si Li, Wenpu Lai, Kai Yin, et al.
Nature Medicine
|
February 27, 2025
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases
Mei-Mei Zheng, Qing Zhou, Hua-Jun Chen, et al.
Cancer Cell
|
March 14, 2025
PAI-1-driven SFRP2<sup>high</sup> cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy
Yan-Pei Zhang, Ze-Qin Guo, Xiao-Ting Cai, et al.
Nature Genetics
|
March 8, 2011
Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population
Fan Wang, Cheng-Qi Xu, Qing He, et al.
Page
of 95
Search research articles
Search
Showing results (941-950 of 947) with videos related to
Sort By:
Page
of 95
You have reached the last page of results.
This site can display upto 947 results.
Cell Reports. Medicine
|
June 19, 2024
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104)
Chao Zhang, Yu-Xuan Sun, Ding-Cheng Yi, et al.
Cell Reports
|
August 8, 2024
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC
Yang-Si Li, Wen-Pu Lai, Kai Yin, et al.
Nature Medicine
|
July 24, 2023
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial
Si-Yang Maggie Liu, Hai-Yan Tu, Xue-Wu Wei, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2025
Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases
Yang-Si Li, Wenpu Lai, Kai Yin, et al.
Nature Medicine
|
February 27, 2025
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases
Mei-Mei Zheng, Qing Zhou, Hua-Jun Chen, et al.
Cancer Cell
|
March 14, 2025
PAI-1-driven SFRP2<sup>high</sup> cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy
Yan-Pei Zhang, Ze-Qin Guo, Xiao-Ting Cai, et al.
Nature Genetics
|
March 8, 2011
Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population
Fan Wang, Cheng-Qi Xu, Qing He, et al.
Page
of 95